Related Experiment Videos
Growth Hormone's Effect on Adipose Tissue: Quality versus Quantity.
Darlene E Berryman1,2, Edward O List3,4
1The Diabetes Institute at Ohio University, 108 Konneker Research Labs, Ohio University, Athens, OH 45701, USA. berrymad@ohio.edu.
International Journal of Molecular Sciences
|September 22, 2017
Summary
Growth hormone (GH) can reduce adipose tissue (AT) mass, but its anti-insulin effects and cancer risks complicate its use. Therapies reducing GH action may offer health benefits for obesity.
Area of Science:
- Endocrinology
- Metabolic Research
- Obesity Science
Background:
- Obesity, characterized by excessive adipose tissue (AT) expansion, is a major public health concern.
- Adipose tissue is more complex than previously understood, necessitating nuanced efficacy measures beyond absolute mass reduction.
- Growth hormone (GH) has lipolytic effects beneficial for reducing AT mass and preserving lean body mass.
Purpose of the Study:
- To review the complexities of adipose tissue in relation to growth hormone (GH) action.
- To summarize current understanding of GH's influence on adipose tissue using human and mouse data.
- To discuss the therapeutic potential of GH or GH antagonists in obesity management.
Main Methods:
- Literature review of recent complexities in adipose tissue biology.
- Analysis of existing human and mouse data on GH and adipose tissue interaction.
- Synthesis of information regarding therapeutic applications and knowledge gaps.
Main Results:
- Adipose tissue is highly dynamic, requiring more than mass reduction to assess therapeutic efficacy.
- GH exhibits potent lipolytic effects but also possesses anti-insulin activities.
- Concerns exist regarding GH's potential role in promoting certain cancers.
Conclusions:
- Therapeutic strategies targeting GH action may be beneficial for obesity and metabolic dysfunction.
- Understanding the complex interplay between GH and adipose tissue is crucial for developing effective obesity treatments.
- Further research is needed to address knowledge gaps concerning GH and adipose tissue in obesity.